Literature DB >> 7684449

Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.

C J Menkes1, M Renoux, S Laoussadi, A Mauborgne, J Bruxelle, F Cesselin.   

Abstract

Experimental results suggest that substance P (SP) may play an important role in pain and inflammation in rheumatic diseases. Measurements of SP-like immunoreactivity (SPLI) were performed in synovial fluid (SF) and synovial tissue from 40 patients with rheumatoid arthritis (RA) or osteoarthritis (OA). High levels of SPLI were found in the SF of patients with RA compared with OA. Conversely, SPLI content in synovial tissue was higher in OA than in RA, suggesting that there is an active secretory process of SPLI into the SF in RA, thus depleting SPLI stores in the synovium. Our data support the involvement of SP in the perpetuation and exacerbation of inflammation in RA, and may also explain some clinical features of this disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684449

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Effect of substance P and somatostatin on migration of polymorphonuclear (PMN) cells in vitro.

Authors:  G Partsch; M Matucci-Cerinic
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

Review 2.  [Peripheral mechanisms of joint pain with special focus on the synovial fibroblast].

Authors:  H Sprott
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

3.  Open access chemical and clinical probes to support drug discovery.

Authors:  Aled M Edwards; Chas Bountra; David J Kerr; Timothy M Willson
Journal:  Nat Chem Biol       Date:  2009-07       Impact factor: 15.040

4.  Mechanisms of oxyradical production in substance P stimulated rheumatoid synovial cells.

Authors:  T Tanabe; H Otani; K Mishima; R Ogawa; C Inagaki
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

5.  Abnormal autonomic cardiovascular control in ankylosing spondylitis.

Authors:  E Toussirot; M Bahjaoui-Bouhaddi; J C Poncet; S Cappelle; M T Henriet; D Wendling; J Regnard
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

6.  Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation?

Authors:  M Matucci-Cerinic; A Lombardi; G Leoncini; A Pignone; L Sacerdoti; M G Spillantini; G Partsch
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

7.  Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes.

Authors:  Hee-Jeong Im; Xin Li; Prasuna Muddasani; Gun-Hee Kim; Francesca Davis; Jayanthi Rangan; Christopher B Forsyth; Michael Ellman; Eugene J M A Thonar
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

Review 8.  Osteoarthritis: symptoms, signs and source of pain.

Authors:  W F Kean; R Kean; W W Buchanan
Journal:  Inflammopharmacology       Date:  2004       Impact factor: 4.473

9.  Effects of medical ozone upon healthy equine joints: Clinical and laboratorial aspects.

Authors:  Cynthia do Prado Vendruscolo; Juliana Junqueira Moreira; Sarah Raphaela Torquato Seidel; Joice Fülber; Henrique Macedo Neuenschwander; Giancarlo Bonagura; Fernanda Rodrigues Agreste; Raquel Yvonne Arantes Baccarin
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

10.  Skin inflammatory reactions to capsaicin in rheumatoid arthritis patients compared to healthy controls.

Authors:  Masoumeh Salari; Roshanak Salari; Houshang Rafatpanah; Yalda Ravanshad; Danial Zirachi; Maryam Sahebari
Journal:  Avicenna J Phytomed       Date:  2019 Jan-Feb
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.